Related Experiment Video
Updated: Jun 29, 2025

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
Research progress on the association between MicroRNA and postoperative cognitive dysfunction
Yuanping Zhong1, Yu Zhang1, Zhaoqiong Zhu2
1Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Postoperative cognitive dysfunction (POCD) is a common surgical complication. This review examines how microRNAs (miRNAs) may contribute to POCD
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Postoperative cognitive dysfunction (POCD) is a significant clinical challenge following surgical procedures.
- The underlying mechanisms of POCD are not fully understood but may involve neuroinflammation, oxidative stress, and apoptosis.
Approach:
- This review synthesizes current research on the role of microRNAs (miRNAs) in the context of POCD.
- It explores the potential involvement of miRNAs in the pathogenesis, diagnosis, and therapeutic strategies for POCD.
Key Points:
- MicroRNAs (miRNAs), small non-coding RNAs, are increasingly recognized for their roles in various biological processes.
- Emerging evidence suggests miRNAs are implicated in neurodegenerative diseases and may influence POCD development.
- Understanding miRNA involvement could offer new diagnostic and therapeutic avenues for POCD.
Conclusions:
- MicroRNAs represent a promising area of investigation for unraveling the complexities of POCD.
- Further research into miRNA-based biomarkers and therapeutics could significantly impact the management of postoperative cognitive dysfunction.
More Related Videos
09:06Stereotactic Injection of MicroRNA-expressing Lentiviruses to the Mouse Hippocampus CA1 Region and Assessment of the Behavioral Outcome
Published on: June 10, 2013
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019